Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF JUNE 09, 2021 SAM #7130
SOLICITATION NOTICE

66 -- Scientific Reagents Supplies

Notice Date
6/7/2021 11:54:31 AM
 
Notice Type
Presolicitation
 
NAICS
325414 — Biological Product (except Diagnostic) Manufacturing
 
Contracting Office
NIH CLINICAL CENTER Bethesda MD 20892 USA
 
ZIP Code
20892
 
Solicitation Number
21-010760
 
Response Due
6/14/2021 11:00:00 AM
 
Archive Date
06/15/2021
 
Point of Contact
Priscilla Abalos
 
E-Mail Address
Priscilla.abalos@nih.gov
(Priscilla.abalos@nih.gov)
 
Small Business Set-Aside
SBP Partial Small Business Set-Aside (FAR 19.5)
 
Description
Requisition # HHSNIHOPCSBSS21-010760 ���������������������� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � ���Notice of Intent to Sole Source The National Institute of Health Office of Purchasing and Contracts intends to negotiate and award a contract to Biolegend Inc., to procure reagents to perform translational research evaluating the pathogenesis and treatment of high-consequence respiratory viral pathogens and inflammation. Respiratory infections are the leading cause of death in children worldwide and result in significant morbidity and mortality. This proposed procurement is for critical delivery services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). The North American Industry Classification System (NAICS) code for this acquisition is 325414 and the size standard number of employees is 1200 This notice of intent to award is not a request for competitive quotations.� Interested concerns capable of providing the same or similar services as described in this notice may submit a capability statement outlining their capabilities.� No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement.� Capability Statements must be received within the time set forth in this synopsis to be considered by the Government.� A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.� The following verbiage is directly from the Justification for Other Than Full and Open Competition (JOFOC).� Sole source determination is based on the need for safe, reliable, and delivery of products notification from the government. All responses are due to the Contract Specialist is June 14,2021 at 2:00 EST Government Official Designated for Receipt of Information Priscilla Abalos Contract Specialist Email:� Priscilla.Abalos@nih.gov Phone:� 301-594-5918 Requisition # HHSNIHOPCSBSS21-010760 ���������������������� ������������� �����������Notice of Intent to Sole Source The National Institute of Health Office of Purchasing and Contracts intends to negotiate and award a contract to Biolegend Inc., to procure reagents to perform translational research evaluating the pathogenesis and treatment of high-consequence respiratory viral pathogens and inflammation. Respiratory infections are the leading cause of death in children worldwide and result in significant morbidity and mortality. This proposed procurement is for critical delivery services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). The North American Industry Classification System (NAICS) code for this acquisition is 325414 and the size standard number of employees is 1200 This notice of intent to award is not a request for competitive quotations.� Interested concerns capable of providing the same or similar services as described in this notice may submit a capability statement outlining their capabilities.� No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement.� Capability Statements must be received within the time set forth in this synopsis to be considered by the Government.� A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.� The following verbiage is directly from the Justification for Other Than Full and Open Competition (JOFOC).� Sole source determination is based on the need for safe, reliable, and delivery of products notification from the government. All responses are due to the Contract Specialist is June 14,2021 at 2:00 EST Government Official Designated for Receipt of Information Priscilla Abalos Contract Specialist Email:� Priscilla.Abalos@nih.gov Phone:� 301-594-5918 Requisition # HHSNIHOPCSBSS21-010760 ���������������������� ������������� �����������Notice of Intent to Sole Source The National Institute of Health Office of Purchasing and Contracts intends to negotiate and award a contract to Biolegend Inc., to procure reagents to perform translational research evaluating the pathogenesis and treatment of high-consequence respiratory viral pathogens and inflammation. Respiratory infections are the leading cause of death in children worldwide and result in significant morbidity and mortality. This proposed procurement is for critical delivery services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). The North American Industry Classification System (NAICS) code for this acquisition is 325414 and the size standard number of employees is 1200 This notice of intent to award is not a request for competitive quotations.� Interested concerns capable of providing the same or similar services as described in this notice may submit a capability statement outlining their capabilities.� No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement.� Capability Statements must be received within the time set forth in this synopsis to be considered by the Government.� A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.� The following verbiage is directly from the Justification for Other Than Full and Open Competition (JOFOC).� Sole source determination is based on the need for safe, reliable, and delivery of products notification from the government. All responses are due to the Contract Specialist is June 14,2021 at 2:00 EST Government Official Designated for Receipt of Information Priscilla Abalos Contract Specialist Email:� Priscilla.Abalos@nih.gov Phone:� 301-594-5918 Requisition # HHSNIHOPCSBSS21-010760 ���������������������� ������������� �����������Notice of Intent to Sole Source The National Institute of Health Office of Purchasing and Contracts intends to negotiate and award a contract to Biolegend Inc., to procure reagents to perform translational research evaluating the pathogenesis and treatment of high-consequence respiratory viral pathogens and inflammation. Respiratory infections are the leading cause of death in children worldwide and result in significant morbidity and mortality. This proposed procurement is for critical delivery services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). The North American Industry Classification System (NAICS) code for this acquisition is 325414 and the size standard number of employees is 1200 This notice of intent to award is not a request for competitive quotations.� Interested concerns capable of providing the same or similar services as described in this notice may submit a capability statement outlining their capabilities.� No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement.� Capability Statements must be received within the time set forth in this synopsis to be considered by the Government.� A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.� The following verbiage is directly from the Justification for Other Than Full and Open Competition (JOFOC).� Sole source determination is based on the need for safe, reliable, and delivery of products notification from the government. All responses are due to the Contract Specialist is June 14,2021 at 2:00 EST Government Official Designated for Receipt of Information Priscilla Abalos Contract Specialist Email:� Priscilla.Abalos@nih.gov Phone:� 301-594-5918 Requisition # HHSNIHOPCSBSS21-010760 ���������������������� ������������� �����������Notice of Intent to Sole Source The National Institute of Health Office of Purchasing and Contracts intends to negotiate and award a contract to Biolegend Inc., to procure reagents to perform translational research evaluating the pathogenesis and treatment of high-consequence respiratory viral pathogens and inflammation. Respiratory infections are the leading cause of death in children worldwide and result in significant morbidity and mortality. This proposed procurement is for critical delivery services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). The North American Industry Classification System (NAICS) code for this acquisition is 325414 and the size standard number of employees is 1200 This notice of intent to award is not a request for competitive quotations.� Interested concerns capable of providing the same or similar services as described in this notice may submit a capability statement outlining their capabilities.� No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement.� Capability Statements must be received within the time set forth in this synopsis to be considered by the Government.� A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.� The following verbiage is directly from the Justification for Other Than Full and Open Competition (JOFOC).� Sole source determination is based on the need for safe, reliable, and delivery of products notification from the government. All responses are due to the Contract Specialist is June 14,2021 at 2:00 EST Government Official Designated for Receipt of Information Priscilla Abalos Contract Specialist Email:� Priscilla.Abalos@nih.gov Phone:� 301-594-5918 Requisition # HHSNIHOPCSBSS21-010760 ���������������������� ������������� �����������Notice of Intent to Sole Source The National Institute of Health Office of Purchasing and Contracts intends to negotiate and award a contract to Biolegend Inc., to procure reagents to perform translational research evaluating the pathogenesis and treatment of high-consequence respiratory viral pathogens and inflammation. Respiratory infections are the leading cause of death in children worldwide and result in significant morbidity and mortality. This proposed procurement is for critical delivery services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). The North American Industry Classification System (NAICS) code for this acquisition is 325414 and the size standard number of employees is 1200 This notice of intent to award is not a request for competitive quotations.� Interested concerns capable of providing the same or similar services as described in this notice may submit a capability statement outlining their capabilities.� No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement.� Capability Statements must be received within the time set forth in this synopsis to be considered by the Government.� A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.� The following verbiage is directly from the Justification for Other Than Full and Open Competition (JOFOC).� Sole source determination is based on the need for safe, reliable, and delivery of products notification from the government. All responses are due to the Contract Specialist is June 14,2021 at 2:00 EST Government Official Designated for Receipt of Information Priscilla Abalos Contract Specialist Email:� Priscilla.Abalos@nih.gov Phone:� 301-594-5918 Requisition # HHSNIHOPCSBSS21-010760 ���������������������� ������������� �����������Notice of Intent to Sole Source The National Institute of Health Office of Purchasing and Contracts intends to negotiate and award a contract to Biolegend Inc., to procure reagents to perform translational research evaluating the pathogenesis and treatment of high-consequence respiratory viral pathogens and inflammation. Respiratory infections are the leading cause of death in children worldwide and result in significant morbidity and mortality. This proposed procurement is for critical delivery services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). The North American Industry Classification System (NAICS) code for this acquisition is 325414 and the size standard number of employees is 1200 This notice of intent to award is not a request for competitive quotations.� Interested concerns capable of providing the same or similar services as described in this notice may submit a capability statement outlining their capabilities.� No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement.� Capability Statements must be received within the time set forth in this synopsis to be considered by the Government.� A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.� The following verbiage is directly from the Justification for Other Than Full and Open Competition (JOFOC).� Sole source determination is based on the need for safe, reliable, and delivery of products notification from the government. All responses are due to the Contract Specialist is June 14,2021 at 2:00 EST Government Official Designated for Receipt of Information Priscilla Abalos Contract Specialist Email:� Priscilla.Abalos@nih.gov Phone:� 301-594-5918 Requisition # HHSNIHOPCSBSS21-010760 ���������������������� ������������� �����������Notice of Intent to Sole Source The National Institute of Health Office of Purchasing and Contracts intends to negotiate and award a contract to Biolegend Inc., to procure reagents to perform translational research evaluating the pathogenesis and treatment of high-consequence respiratory viral pathogens and inflammation. Respiratory infections are the leading cause of death in children worldwide and result in significant morbidity and mortality. This proposed procurement is for critical delivery services for which the government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b). The North American Industry Classification System (NAICS) code for this acquisition is 325414 and the size standard number of employees is 1200 This notice of intent to award is not a request for competitive quotations.� Interested concerns capable of providing the same or similar services as described in this notice may submit a capability statement outlining their capabilities.� No solicitation is available. Information received will be evaluated for the purpose of determining whether to conduct a competitive procurement.� Capability Statements must be received within the time set forth in this synopsis to be considered by the Government.� A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.� The following verbiage is directly from the Justification for Other Than Full and Open Competition (JOFOC).� Sole source determination is based on the need for safe, reliable, and delivery of products notification from the government. All responses are due to the Contract Specialist is June 14,2021 at 2:00 EST Government Official Designated for Receipt of Information Priscilla Abalos Contract Specialist Email:� Priscilla.Abalos@nih.gov Phone:� 301-594-5918
 
Web Link
SAM.gov Permalink
(https://beta.sam.gov/opp/123d661c3a9843e3a74828d11fd6f019/view)
 
Place of Performance
Address: Bethesda, MD 20892, USA
Zip Code: 20892
Country: USA
 
Record
SN06024096-F 20210609/210608201655 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.